Neurofibrillary tangles and senile plaques in Alzheimer's brains are associated with reduced capillary expression of vascular endothelial growth factor and endothelial nitric oxide synthase

Current Neurovascular Research

Volumn 5, Issue 3, 2008, Pages 199-205

  Provias, John ^a   Jeynes, Brian ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b BROCK UNIVERSITY   (Canada)

Author keywords

AD lesions; Blood brain barrier; VEGF and eNOS positive capillaries

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; ENDOTHELIAL NITRIC OXIDE SYNTHASE; TAU PROTEIN; VASCULOTROPIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENILE PLAQUE;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BLOOD-BRAIN BARRIER; BRAIN; CAPILLARIES; DOWN-REGULATION; ENDOTHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEUROFIBRILLARY TANGLES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; SENILE PLAQUES; TAU PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 49949084427     PISSN: 15672026     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720208785425729     Document Type: Article

References (45)

1. Aliyev, A, Seyidova, D, Rzayev, N, Obrenovich, ME, Lamb, BT, Chen, SG, Smith, MA, Perry, G, De la Torre, JC, Aliev, G. (2004) Is nitric oxide a key target in the pathogenesis of brain lesions during the development of Alzheimer's disease? Neurol Res 26: 547-553.
2. Attems, J. (2005) Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms. Acta Neuropathol 110: 345-359.
3. Blum-Degen, D, Heinemann, T, Lan, J. (1999) Characterization and regional distribution of nitric oxide synthase in the human brain during normal aging. Brain Res 834: 128-135.
4. Braak, H, Braak, E. (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berl) 82: 239-259.
5. Byrne, AM, Boucher-Hayes, DJ, Harmey, JH. (2005) Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J Cell Mol Med 9: 777-794.
6. Canuelo, A, Siles, E, Martinez-Romero, R, Peinado, MA, Martinez-Lara, E. (2007) The nitric oxide system response to hypoxia/reoxygenation in the aged cerebral cortex. Exp Gerentol 42: 1137-1145.
7. Chapuis, J, Tian, J, Shi, J, Bensemain, F, Cottel, D, Lendon, C, Amouyel, P, Mann, D, Lambert, J-C. (2006) Association study of the vascular endothelial growth factor gene with the risk of developing Alzheimer's disease. Neurobiol Aging 27: 1212-1215.
8. De la Torre, JC, Aliev, G. (2005) Inhibition of vascular nitric oxide after rat chronic brain hypoperfusion: spatial memory and immunocytochemical changes. J Cereb Blood Flow Metab 25: 663-672.
9. Del Bo, R, Scarloto, M, Ghezzi, S, Boneschi, FM, Fenoglio, C, Galbiati, S, Virgilio, R, Galimberti, D,Galimberti, G, Crimi, M, Ferrarese, C, Scarpini, E, Bresolin, N, Comi, GP. (2005) Vascular endothelial growth factor gene variability is associated with increased risk for AD. Ann Neurol 57: 373-380.
10. Ding, YH, Li, J, Zhou, Y, Rafois, JA, Clark, JC, Ding, Y. (2006) Cerebral angiogenesis and expression of angiogenic factors in aging rats after exercise. Curr Neurovasc Res 3: 15-23.
11. Dvorak, HF. (2006) Discovery of vascular permeability factor (VPF). Exp Cell Res 312: 522-526.
12. Emerich, DF, Schneider, P, Bintz, B, Hudak, J, Thanos, CG. (2007) Aging reduces the neuroprotective capacity, VEGF secretion, and metabolic activity of rat choroid plexus epithelial cells. Cell Transplant 16: 697-705.
13. Faraci, FM. (2006) Protecting the brain with eNOS: Run for your life. Circ Res 99: 1029-1030.
14. Ferrara, N, Gerber, H-P, LeCouter, J. (2003) The biology of VEGF and its receptors. Nat Med 9: 669-676.
15. Gora-Kupilas, K, Josko, J. (2005) The neuroprotective function of vascular endothelial growth factor (VEGF). Folia Neuropathol 43: 31-39.
16. Greenberg, DA, Jin, K. (2005) From angiogenesis to neuropathology. Nature 438: 954-959.
17. Guix, FX, Uribesalgo, I, Coma, M, Munoz, FJ. (2005) The physiology and pathophysiology of nitric oxide in the brain. Progr Neurobiol 76: 126-152.
18. Han, F, Ali Raie, A, Shioda, N, Qin, Z-H, Fukunaga, K. (2008) Accumulation of beta-amyloid in the brain microvessels accompanies increased hyperphosphorylated tau proteins following microsphere embolism in aged rats. Neuroscience 153: 414-427.
19. 165 in the brain. NeuroImage 39: 1549-1558.
20. Herttuala, SY, Rissanen, TT, Vajanto, I. (2007) Vascular endothelial growth factors. J Am J Cardiol 49: 1015-1026.
21. Hoehn, BD, Harik, SI, Hudetz, AG. (2002) VEGF mRNA expressed in microvessels of neonatal and adult rat cerebral cortex. Mol Brain Res 101: 103-108.
22. Infante, J, Mateo, I, Rodriguez, E. (2007) VEGF serum levels are not associated with Parkinson's disease. Eur J Neurol 14: e6.
23. Jeynes, B, Provias, J. (2006) The possible role of capillary cerebral amyloid angiopathy in Alzheimer lesion development: a regional comparison. Acta Neuropathol 112: 417-427.
24. Kalaria, RN, Cohen, DL, Premkumar, DR, Nag, S, La-Manna, JC. (1998) Vascular endothelial growth factor: in Alzheimer's disease and experimental cerebral ischemia. Brain Res Mol Brain Res 62: 101-105.
25. Kaur, C, Ling, EA. (2008) Blood brain barrier in hypoxic-ischemic conditions. Curr Neurovasc Res 5: 71-81.
26. Krizanac-Bengez, L, Kapural, M, Parkinson, F, Cucullo, L, Hossain, M, Mayberg, MR, Janigro, D. (2003) Effects of transient loss of shear stress on blood-brain barrier endothelium: role of nitric oxide and Il-6. Brain Res 977: 239-246.
27. Liu, P, Smith, PF, Appleton, I, Darlington, CL, Bilky, DK. (2004) Age-related changes in nitric oxide synthase and arginase in the rat prefrontal cortex. Neurobiol Aging 25: 547-552.
28. Malinski, T. (2007) Nitric oxide and nitroxidative stress in Alzheimer's disease. J Alzheimers Dis 11: 207-218.
29. Mateo, I, Llorca, J, Infante, J, Rodriguez-Rodriguez, E, Sanchez-Quintana, C, Sanchez-Juan, P, Berciano, J, Combarros, O. (2006) Case-control study of vascular endothelial growth factor (VEGF) genetic variability in Alzheimer's disease. Neurosci Lett 401: 171-173.
30. McCann, SM, Mastronardi, C, de Laurentiis, A, Rettori, V. (2005) The nitric oxide theory of aging revisited. Ann N Y Acad Sci 1057: 64-84.
31. Moser, KV, Humpel, C. (2005) Vascular endothelial growth factor counteracts NMDA-induced cell death of adult cholinergic neurons in rat basal nucleus of Meynert. Brain Res Bull 65: 125-131.
32. Park, S-Y, Chae, C-B. (2007) Toxic levels of amyloid beta peptide do not induce VEGF synthesis. Mol Cells 24: 69-75.
33. Paton, JF, Waki, H, Abdala, AP, Dickinson, J, Kasparov, S. (2007) Vascular-brain signaling in hypertension: role of angiotensin II and nitric oxide. Curr Hypertens Rep 9: 242-247.
34. Pluta, R. (2006) Is the ischemic blood-brain barrier insufficiency responsible for full-blown Alzheimer's disease? Neurol Res 28: 665-671.
35. Prezedborski, S, Jackson-Lewis, V, Yokoyama, R, Shibata, T, Dawson, VL, Dawson, TM. (1996) Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6- tetrahydtopyridine (MPTP)-induced dopaminergic neurotoxicity. Proc Natl Acad Sci 93: 4565-4571.
36. Sohn,YK, Ganju, NG, Bloch, KD, Wands, JR, de la Monte, SM. (1999) Neuritic sprouting with aberrant expression of the nitric oxide synthase III gene in neurodegenerative diseases. J Neurol Sci 162: 133-151.
37. Storkebaum, E, Lambrechts, D, Carmeliet, P. (2004) VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays 26: 943-954.
38. Strosznajder, JB, Jesko, H, Zambrzycka, A, Eckert, A, Chalimoniuk, M. (2004) Age-related alteration of activity and gene expression of endothelial nitric oxide synthase in different parts of the brain in rats. Neurosci Lett 370: 175-179.
39. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. (1991) Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41: 479-486.
40. Thirumangalakudi, L, Samany, PG, Owoso, A, Wiskar, B, Grammas, P. (2006) Angiogenic proteins are expressed by brain blood vessels in Alzheimer's disease. J Alzheimers Dis 10: 111-118.
41. Togo, T, Katsuse, O, Iseki, E. (2004) Nitric oxide pathways in Alzheimer's disease and other neurodegenerative dementias. Neurol Res 26: 563-566.
42. Weller, RO, Yow, HY, Preston, SD, Mizanti, I, Nicol, JA. (2002) Cerebrovascular disease is a major factor in the failure of elimination of A beta from the aging human brain: implications for therapy of Alzheimer's disease. Ann N Y Acad Sci 977: 162-168.
43. Yang, SP, Bae, DG, Kang, HJ, Gwag, BJ, Gho, YS, Chae, CB. (2004) Co-accumulation of vascular endothelial growth factor with beta-amyloid in the brain of patients with Alzheimer's disease. Neurobiol Aging 25: 283-290.
44. 165 with β-amyloid induced neurotoxicity. J Neurochem 93: 118-127.
45. Zlokovic, BV, Deanne, R, Sallstrom, J, Chow, N, Miano, JM. (2005) Neurovascular pathways and Alzheimer amyloid β-peptide. Brain Pathol 15: 78-83.